Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current status of our knowledge on TRH]

R Usategui, C Oliver, F Gandia

    Revista Clinica Espanola
    |November 15, 1977
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Naxitamab: a humanized anti-glycolipid disialoganglioside (anti-GD2) monoclonal antibody for treatment of neuroblastoma.

    Drugs of today (Barcelona, Spain : 1998)·2021
    Same author

    First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer<sup>☆</sup>.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    Capmatinib for non-small cell lung cancer.

    Drugs of today (Barcelona, Spain : 1998)·2021
    Same author

    Zanubrutinib: a new BTK inhibitor for treatment of relapsed/refractory mantle cell lymphoma.

    Drugs of today (Barcelona, Spain : 1998)·2020
    Same author

    Avapritinib for metastatic or unresectable gastrointestinal stromal tumors.

    Drugs of today (Barcelona, Spain : 1998)·2020
    Same author

    Tazemetostat for the treatment of multiple types of hematological malignancies and solid tumors.

    Drugs of today (Barcelona, Spain : 1998)·2020